Sublesional Bone Loss Secondary to SCI

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06643Denosumab2Recruiting1
DB11866Romosozumab2Recruiting1